Skip to content

AtriCure ATRC Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

ITG
Integer HoldingsITGR
$1.63M-13.7%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$577K-33.4%

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's debt issuance cost amortization?
AtriCure (ATRC) reported debt issuance cost amortization of $105K in Q1 2026.
How has AtriCure's debt issuance cost amortization changed year-over-year?
AtriCure's debt issuance cost amortization decreased by 12.5% year-over-year, from $120K to $105K.
What is the long-term trend for AtriCure's debt issuance cost amortization?
Over 4 years (2021 to 2025), AtriCure's debt issuance cost amortization has grown at a -10.9% compound annual growth rate (CAGR), from $759K to $478K.
What does debt issuance cost amortization mean?
Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).